Zekun Lang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Zekun Lang has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Jing Yu
Department of Cardiology, Lanzhou University Second Hospital, Lanzhou, China
1 shared publication - Mahboob Alam
Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA
1 shared publication - Miaomiao Qi
Hypertension Center, Lanzhou University Second Hospital, Lanzhou University, Lanzhou, China; and
1 shared publication - Tingting Fang
Department of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China
1 shared publication - Yingqiang Guo
Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China
1 shared publication - Zeyi Cheng
Department of Cardiac Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Ruijin 2nd Road, Huangpu district , Shanghai, 200025
1 shared publication
Latest Publications
- 8 September 2021
- Published by IMR Press in The Heart Surgery Forum
- Vol. 24 (5) , E887-E892
Peripheral Artery Disease on The Prognosis Value of Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Retrospective, Single-Center Cohort Study
Objective: The purpose of this investigation aimed to clarify the impact of peripheral artery disease (PAD) on the prognosis value of patients with stable coronary artery disease (CAD) who underwent percutaneous coronary intervention (PCI). Methods: The SPSS 16 software was used for secondary analysis of DRYAD database data. A total of 204 patients were enrolled from Shinonoi General Hospital for newly diagnosed stable CAD and received PCI performance between October 2014 and October 2017. Patients with old myocardial infarction (MI) were excluded. We divided patients into two groups with PAD and without PAD. The primary endpoints were major adverse cardiac events (MACE, defined as all-cause death, non-fatal MI, and non-fatal stroke) and cardiovascular events (defined as cardiovascular death, non-fatal MI, and non-fatal stroke). The secondary outcomes were the individual components of the composite primary outcomes. The median follow-up time was 783 days. Results: No statistical difference was found between PAD and non-PAD patients of lesional characteristics. Spearman’s rank correlations indicate diabetes mellitus (DM) (P = 0.019) and HbA1c (P = 0.009) are positively correlated with PAD. In Kaplan-Meier analysis, patients with PAD predicted poor prognosis in MACE (P < 0.05) and cardiovascular events (P < 0.05). In Multivariable Cox proportional hazards analysis, patients with PAD independently predicted MACE and cardiovascular events. Conclusions: PAD is a significant mediator for the prognosis of patients with stable CAD who underwent PCI treatment.
- 8 September 2021
- Published by IMR Press in The Heart Surgery Forum
- Vol. 24 (5) , E887-E892
Peripheral Artery Disease on The Prognosis Value of Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Retrospective, Single-Center Cohort Study
Objective: The purpose of this investigation aimed to clarify the impact of peripheral artery disease (PAD) on the prognosis value of patients with stable coronary artery disease (CAD) who underwent percutaneous coronary intervention (PCI). Methods: The SPSS 16 software was used for secondary analysis of DRYAD database data. A total of 204 patients were enrolled from Shinonoi General Hospital for newly diagnosed stable CAD and received PCI performance between October 2014 and October 2017. Patients with old myocardial infarction (MI) were excluded. We divided patients into two groups with PAD and without PAD. The primary endpoints were major adverse cardiac events (MACE, defined as all-cause death, non-fatal MI, and non-fatal stroke) and cardiovascular events (defined as cardiovascular death, non-fatal MI, and non-fatal stroke). The secondary outcomes were the individual components of the composite primary outcomes. The median follow-up time was 783 days. Results: No statistical difference was found between PAD and non-PAD patients of lesional characteristics. Spearman’s rank correlations indicate diabetes mellitus (DM) (P = 0.019) and HbA1c (P = 0.009) are positively correlated with PAD. In Kaplan-Meier analysis, patients with PAD predicted poor prognosis in MACE (P < 0.05) and cardiovascular events (P < 0.05). In Multivariable Cox proportional hazards analysis, patients with PAD independently predicted MACE and cardiovascular events. Conclusions: PAD is a significant mediator for the prognosis of patients with stable CAD who underwent PCI treatment.